Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2014
04/23/2014CN103735939A Lipid-lowering Chinese medicinal composition and preparation method thereof
04/23/2014CN103735925A Formula of traditional Chinese medicine for treating diabetic nephropathy
04/23/2014CN103735897A Traditional Chinese medicine oral liquid for lowering blood pressure and regulating blood fat and preparation method thereof
04/23/2014CN103735896A Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof
04/23/2014CN103735888A Traditional Chinese medicine formula for treatment of diabetes
04/23/2014CN103735887A Traditional Chinese medicine formula for treatment of diabetes
04/23/2014CN103735886A Formula of diabetes treatment traditional Chinese medicine
04/23/2014CN103735880A Traditional Chinese medicine for treating hypertension and hyperglycemia and preparation method thereof
04/23/2014CN103735843A Medicine composition for treating diabetes
04/23/2014CN103735839A Traditional Chinese medicine external application agent for treating diabetic foot
04/23/2014CN103735793A Traditional Chinese medicine for treating limb numbness of diabetics after stroke and preparation method thereof
04/23/2014CN103735782A Sea cucumber intestine extract composite soft capsules and preparation method thereof
04/23/2014CN103735778A Traditional Chinese medicine composition for treating obesity
04/23/2014CN103735769A Pharmaceutical composition capable of decreasing blood sugar as well as preparation method and application thereof
04/23/2014CN103735754A Preparation method of lipid-lowering medicine
04/23/2014CN103735739A Slimming composition and preparation method thereof
04/23/2014CN103735737A Composition for treating hyperlipemia
04/23/2014CN103735687A Slimming composition and preparation method thereof
04/23/2014CN103735678A Diabetes resistance preparation
04/23/2014CN103735666A Blood fat reducing preparation
04/23/2014CN103735664A Composition for treating hyperlipemia
04/23/2014CN103735663A Traditional Chinese medicine for reducing blood glucose and preparation method thereof
04/23/2014CN103735654A Traditional Chinese medicine extractive having bidirectional immunity adjustment effect and application
04/23/2014CN103735648A Drug for treating diabetes
04/23/2014CN103735643A Traditional Chinese medicine composition for treating diabetic peripheral neuropathy
04/23/2014CN103735623A Auxiliary blood fat reducing tablet
04/23/2014CN103735621A Chinese medicinal composition with blood lipid reducing and immunity enhancing effects
04/23/2014CN103735609A Blood fat reducing preparation
04/23/2014CN103735607A Novel injection composition for packaging fat emulsion and amino acid (17) glucose (11 percent)
04/23/2014CN103735603A Compound lipid-decreasing soft capsule and preparation method thereof
04/23/2014CN103735556A Multivitamin mineral composite effervescent tablet and preparation method thereof
04/23/2014CN103735544A Preparing process for vildagliptin/metformin hydrochloride compound preparation
04/23/2014CN103735540A Calcium gluconate aqueous solution with high calcium content and preparation method thereof
04/23/2014CN103735537A Application of xanthohumol in preparation of drug or health-care product for inhibiting alpha-glucosaccharase activity
04/23/2014CN103734844A Healthcare cola
04/23/2014CN103734823A Compound donkey-hide gelatin lyceum-barbarum beverage and preparation method thereof
04/23/2014CN103734751A Composite dietary fiber and preparation method thereof
04/23/2014CN103734746A Use of aspartate for regulating glucose levels in blood
04/23/2014CN103734425A Health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid and preparation method of tea
04/23/2014CN103734385A Tea granule for relieving diabetes mellitus and preparation method thereof
04/23/2014CN103251887B Pharmaceutical composition for treating diabetes and indications thereof
04/23/2014CN102993289B Scolopendra mutilans polypeptide toxin kappa-SLPTX-Ssm4a and gene and application thereof
04/23/2014CN102861192B Medicine composition for chronic renal failure and peritoneal fibrosis
04/23/2014CN102836204B Kudzuvine root extracts and preparation thereof
04/23/2014CN102836188B Folium microcotis total flavone extract and preparation method and application thereof
04/23/2014CN102805858B High-efficiency calcium supplement capsule and preparation method thereof
04/23/2014CN102600438B Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease
04/23/2014CN102526147B Method for purifying panax notoginseng total saponins and preparation of panax notoginseng total saponins
04/23/2014CN102503932B Novel gas signal molecule donator and preparation method and use thereof
04/23/2014CN102388038B Benzofuranyl derivatives used as glucokinase inhibitors
04/23/2014CN102356068B 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
04/23/2014CN102302592B Preparation technology and purpose of citrus grandis peel flavones
04/23/2014CN102143956B Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
04/23/2014CN102133416B Compound protein air-purifying deodorizer (deodorant liquid)
04/23/2014CN102018655B Transdermal medicament delivery combined preparation
04/23/2014CN101952280B Bicyclic heterocyclic derivative
04/23/2014CN101910131B Carboxamide, sulfonamide and amine compounds and usagmethod thereof
04/23/2014CN101805349B Furan-azo- [3,2-g] chromene compound and application thereof
04/23/2014CN101790311B Benzylbenzene derivatives and methods of use
04/23/2014CN101511819B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
04/22/2014US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/22/2014US8703759 Fused heterocyclic compounds as ion channel modulators
04/22/2014US8703752 Use of mifepristone and derivatives therefor as Hedgehog protein signaling pathway modulators and applications of same
04/22/2014US8703745 Compounds as receptor modulators with therapeutic utility
04/22/2014US8703701 Glucagon/GLP-1 receptor co-agonists
04/22/2014US8703213 Anti-diabetic composition containing a plant extract of Englerina lecardii
04/22/2014US8703199 Pharmaceutical compositions of adsorbates of amorphous drug
04/22/2014US8703182 Light-stabilized soft capsule formulations
04/22/2014US8703155 Method of stabilizing reduced coenzyme q10
04/22/2014CA2781292C Novel spiropiperidine compounds
04/22/2014CA2770404C Amide derivative
04/22/2014CA2764021C Gpr 119 modulators
04/22/2014CA2751187C Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
04/22/2014CA2728202C Composition for addition to drinking water
04/22/2014CA2637771C Anthranilamide/2-amino-heteroarene carboxamide derivatives
04/22/2014CA2628790C Novel quinolizidine and octahydropyridopyrazine compounds
04/22/2014CA2611451C Solid preparation
04/22/2014CA2345209C Antisense modulation of integrin .alpha.4 expression
04/17/2014WO2014059383A1 Gsk3 inhibitors and methods of use thereof
04/17/2014WO2014059245A1 Compositions and methods for sustained delivery of glucagon-like peptide (glp-1) receptor agonist therapeutics
04/17/2014WO2014058441A1 Method of weight management
04/17/2014WO2014058142A1 Pharmaceutical composition containing aster glehni extract as active ingredientfor preventing or treating obesity or metabolic diseases
04/17/2014WO2014058083A1 Composition containing poly-gamma glutamic acid for improving blood triglyceride levels
04/17/2014WO2014058000A1 Serotonin 2b receptor antagonist
04/17/2014WO2014057727A1 Method for manufacturing substance containing nobiletin and tangeretin derived from citrus fruits, and nobiletin- and tangeretin-containing substance obtained thereby
04/17/2014WO2014057455A2 Influenza virus and type 1 diabetes
04/17/2014WO2014057408A1 Methods for increasing insulin sensitivity by agonists of serotonergic receptors 5-ht2
04/17/2014WO2014057024A1 Formulations for the treatment and prevention of obesity
04/17/2014WO2014056938A1 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
04/17/2014WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors
04/17/2014WO2014056333A1 Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor
04/17/2014WO2014056280A1 Microencapsulated amino acid composition and preparation method thereof
04/17/2014WO2014036528A3 Agents useful for treating obesity, diabetes and related disorders
04/17/2014US20140107160 Ccr9 inhibitors and methods of use thereof
04/17/2014US20140107116 Benzothiazole derivatives for the treatment of diabetes
04/17/2014US20140107067 Compositions comprising dietary fat complexers and methods for their use
04/16/2014EP2719390A1 Carbon-monoxide(co)-assisted inhibition of fatty acid and cholesterol uptake
04/16/2014EP2719287A1 Compositions for the treatment of hyperlipidemia
04/16/2014EP2718331A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof
04/16/2014EP2718318A2 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 1298